Indian Journal of Palliative Care
Open access journal 
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size Users online: 372  
     Home | About | Feedback | Login 
  Current Issue Back Issues Editorial Board Authors and Reviewers How to Subscribe Advertise with us Contact Us Analgesic Prescription  
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
  »  Article in PDF (403 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  References

 Article Access Statistics
    Viewed2168    
    Printed87    
    Emailed0    
    PDF Downloaded59    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
Table of Contents 
LETTER TO EDITOR
Year : 2011  |  Volume : 17  |  Issue : 3  |  Page : 260

Authors' reply


1 Hematology Unit, S. Eugenio Hospital, Rome, Italy
2 Hematology, Department of Cellular Biotechnologies and Hematology, University "La Sapienza", Rome, Italy
3 Laboratory Medicine, "Sandro Pertini" Hospital, Rome, Italy

Date of Web Publication28-Jan-2012

Correspondence Address:
Pasquale Niscola
Hematology Unit, S. Eugenio Hospital, Rome
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 22346057

Rights and PermissionsRights and Permissions



How to cite this article:
Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P. Authors' reply. Indian J Palliat Care 2011;17:260

How to cite this URL:
Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P. Authors' reply. Indian J Palliat Care [serial online] 2011 [cited 2020 Sep 20];17:260. Available from: http://www.jpalliativecare.com/text.asp?2011/17/3/260/92357


Sir,

The recent comment by Wiwanitkit [1] to our paper on anticoagulant (AC) and antiplatelet (AP) agents in the management of hematological malignancies in a home-care program [2] was valuable and interesting.

The author concluded, "This is no doubt the reason why the use of AC/AP in home healthcare seems to be uncommon in this report" [1] and "There appears to be a high incidence of complications or adverse events of AC/AP drugs in clinical practice and, therefore, the use of these drugs in home healthcare for cases with hematological malignancies might be considered a risk". [1] Our opinion, however, is that firstly the frequency of use of the AC/AP in our case series is difficult to evaluate, being not properly comparable with similar realities, given the heterogeneity of both patients and AC/AP treatment indications; secondly, even the frequency of hemorrhagic complications there seems at least not higher than that observed in similar populations of patients. [3] Therefore, we believe that it is at least hasty to conclude that the use of AC/AP therapy in our series has been more limited than expected due to an excessive rate of bleeding complications.

Finally, we are extremely favorable to the dissemination and patient use of point-of-care testing (POCT) analyzer systems, while not believing that this should necessarily favor the spread of the use of AC/AP in home managed hematological patients.

 
 » References Top

1.Wiwanitkit V. Anticoagulants and anti-platelet agents in palliative home healthcare. Indian J Palliat Care 2011;17:260.  Back to cited text no. 1
  Medknow Journal  
2.Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, et al. Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program. Indian J Palliat Care 2011;17:54-6.  Back to cited text no. 2
[PUBMED]  Medknow Journal  
3.Cartoni C, Niscola P, Breccia M, Brunetti G, D'Elia GM, Giovannini M, et al. Hemorrhagic complications in patients with advanced hematological malignancies followed at home: An Italian experience. Leuk Lymphoma 2009;50:387-91.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  



This article has been cited by
1 Authors′ reply
Tendas, A. and Cupelli, L. and Scaramucci, L. and Palombi, M. and Trawinska, M.M. and Giovannini, M. and Brunetti, G.A. and Cartoni, C. and Bondanini, F. and De Fabritiis, P. and Niscola, P.
Indian Journal of Palliative Care. 2011; 17(3): 260-261
[Pubmed]



 

Top
Print this article  Email this article
Online since 1st October '05
Published by Wolters Kluwer - Medknow